LINC02465: A Long Intergenic Non-Protein-Coding RNA (G107986313)

Target Name: LINC02465

NCBI ID: G107986313

LINC02465

Other Name(s): long intergenic non-protein coding RNA 2465 | Long intergenic non-protein coding RNA 2465

LINC02465: A Long Intergenic Non-Protein-Coding RNA

Non-Protein-Coding RNAs (NP-C RNAs) have emerged as a promising source of new biomarkers and drug targets in recent years. These RNAs are generated from genomic regions that are not involved in protein production, but can be expressed and translated into functional proteins or RNA molecules. One class of NP-C RNAs is called Long Intergenic Non-Protein-Coding RNAs (LINC RNAs), which are characterized by their longer than average sizes and their diverse functions. In this article, we will focus on LINC02465, a novel LINC RNA that has potential as a drug target or biomarker.

LINC02465 is a 2465-nt RNA molecule that is generated from the intergenic region between exons 11 and 12 of the human gene ATG. This region is known as the long non-coding RNA (lncRNA) gene, and is often characterized by the presence of transcribed repetitive sequences and other non-coding elements. LINC02465 is expressed in various cell types and is highly stable in the cell, which suggests that it may have important functions in these cells.

One of the defining features of LINC02465 is its size. LINC RNAs are often characterized by their long size, which allows them to interact with various cellular components and molecules. The size of LINC02465 is particularly noteworthy, as it is one of the longest known LINC RNA molecules. This length may be important for its function, as it allows the RNA to have a large enough structure to interact with other molecules and to be stable in the cell.

Another feature of LINC02465 is its expression. LINC RNAs are often expressed in various cell types, but the levels of expression can vary depending on the cell type and the conditions in the cell. LINC02465 is expressed in many tissues and cells, including the brain, heart, and liver. This suggests that it may have important functions in these tissues, and that its expression may be regulated by various factors, including gene expression networks and cellular signaling pathways.

In addition to its size and expression, LINC02465 has other characteristics that are relevant to its potential as a drug target or biomarker. For example, it has a high degree of sequence conservation, with only a few differences in the amino acid sequences at its conserved regions. This suggests that it may have similar or complementary functions to other molecules, and that its sequence may be relevant for its stability or stability-related functions. Additionally, LINC02465 has been shown to interact with various cellular components, including proteins and non-coding RNA. This suggests that it may play a role in the regulation of cellular processes and may be a useful target for drugs that target these processes.

In conclusion, LINC02465 is a novel and promising LINC RNA that has potential as a drug target or biomarker. Its long size and stable expression, as well as its conservation in sequence and interactions with cellular components, suggest that it may have important functions in various cell types and that its functions may be relevant to the development of new therapeutics. Further research is needed to determine the exact functions of LINC02465 and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2465

The "LINC02465 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02465 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets